SCHEMBL9176540

SCHEMBL9176540

c1cc(C2(c3ccc(OCC4CO4)cc3)CC3CC2C2CCCC32)ccc1OCC1CO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ MAPT P10636 4/20 0.44
▸ TP53 P04637 3/20 0.44
▸ TSHR P16473 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HIF1A Q16665 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.42
▸ PKM P14618 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ OPRM1 P35372 1/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ ALOX5AP P20292 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL158352 0.81 ALDH1A1 (0.44) ALDH1A1MAPTTP53TSHRHPGD
SCHEMBL7010144 0.80 ALOX5AP (0.54) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL9176534 0.79 ALDH1A1 (0.44) ALDH1A1MAPTTP53TSHRHPGD
SCHEMBL5599199 0.75 TDP1 (0.41) ALDH1A1MAPTTP53TSHRHPGD
SCHEMBL14804292 0.73 ALDH1A1 (0.42) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL24556914 0.72 LTA4H (0.38) PKMGAAOPRM1
SCHEMBL29411927 0.72 TDP1 (0.68) ALDH1A1MAPTTP53TSHRHPGD
SCHEMBL159569 0.72 ALOX5AP (0.64) ALDH1A1MAPTTP53TSHRHPGD
SCHEMBL28633766 0.71 ALDH1A1 (0.44) ALDH1A1MAPTTP53TSHRHPGD
SCHEMBL21094081 0.70 TDP1 (0.79) ALDH1A1MAPTTP53TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10870724-B2 High heat monomers and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-12-22 — — US disclosed
US-10465037-B2 High heat monomers and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-11-05 — — US disclosed
US-20190322653-A1 METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-10-24 — — US disclosed
US-20170158806-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-08 — — US disclosed
US-20170158806-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-08 — — US disclosed
WO-2016014536-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-01-28 — — WO disclosed
EP-0325058-B1 Improved epoxide resin compositions and method MINNESOTA MINING & MFG (US) 1995-05-17 — — EP disclosed
US-5073595-A Fluorene chain extender; improved glass transition temperature toughness MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-12-17 — — US disclosed
US-5045363-A Chain extended with a 9,9-bis(hydroxyphenyl)fluorene compound, improved toughness, adhesive bonding film MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-09-03 — — US disclosed
US-4983672-A Containing 9,9-bis(hydroxyphenyl)fluorene MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-01-08 — — US disclosed
US-4980234-A CONTAINING SUBSTITUTED FLUORENE UNITS MINNESOTA MINING AND MANUFACTURING CO. (US) 1990-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10870724-B2 High heat monomers and methods of use thereof HSP90AA1, HSP90AB1, EPHX2 ALDH1A1 318/4885MAPT 969/4885TP53 710/4885
US-20170158806-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF HSP90AA1, HSP90AB1, EPHX2 ALDH1A1 318/4885MAPT 969/4885TP53 710/4885
US-10465037-B2 High heat monomers and methods of use thereof HSP90AA1, HSP90AB2P, HSP90AB1 ALDH1A1 295/4885MAPT 990/4885TP53 794/4885
US-20190322653-A1 METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM EPHX2, EPHX1, CYP2F1 ALDH1A1 138/4885MAPT 4864/4885TP53 3230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback